Terpenoids: Opportunities for Biosynthesis of Natural Product Drugs Using Engineered Microorganisms
- 21 March 2008
- journal article
- review article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 5 (2), 167-190
- https://doi.org/10.1021/mp700151b
Abstract
Terpenoids represent a diverse class of molecules that provide a wealth of opportunities to address many human health and societal issues. The expansive array of structures and functionalities that have been evolved in nature provide an excellent pool of molecules for use in human therapeutics. While this class of molecules has members with therapeutic properties including anticancer, antiparasitic, antimicrobial, antiallergenic, antispasmodic, antihyperglycemic, anti-inflammatory, and immunomodulatory properties, supply limitations prevent the large scale use of some molecules. Many of these molecules are only found in ppm levels in nature thus requiring massive harvesting to obtain sufficient amounts of the drug. Synthetic biology and metabolic engineering provide innovative approaches to increase the production of the desired molecule in the native organism, and most importantly, transfer the biosynthetic pathways to other hosts. Microbial systems are well studied, and genetic manipulations allow the optimization of microbial metabolisms for the production of common terpenoid precursors. Using a host of tools, unprecedented advancements in the large scale production of terpenoids have been achieved in recent years. Identification of limiting steps and pathway regulation, coupled with design strategies to minimize terpenoid byproducts wih a high flux to the desired biosynthetic pathways, have yielded greater than 100-fold improvements in the production of a range of terpenoids. This review focuses on the biodiversity of terpenoids, the biosynthetic pathways involved, and engineering efforts to maximize the production through these pathways.Keywords
This publication has 98 references indexed in Scilit:
- Expanding the metabolic engineering toolbox: more options to engineer cellsTrends in Biotechnology, 2007
- Crystal Structures of Human IPP Isomerase: New Insights into the Catalytic MechanismJournal of Molecular Biology, 2007
- Administering cultured Taxus cells with early precursors reveals bifurcations in the taxoid biosynthetic pathwayPhytochemistry, 2007
- Biotransformation of terpenesBiotechnology Advances, 2006
- fldA is an essential gene required in the 2‐C‐methyl‐D‐erythritol 4‐phosphate pathway for isoprenoid biosynthesisFEBS Letters, 2005
- The Crystal Structure of E.coli 1-Deoxy-d-xylulose-5-phosphate Reductoisomerase in a Ternary Complex with the Antimalarial Compound Fosmidomycin and NADPH Reveals a Tight-binding Closed Enzyme ConformationJournal of Molecular Biology, 2005
- Natural products as a hunting ground for combinatorial chemistryCurrent Opinion in Biotechnology, 2004
- Higher plant terpenoids: A phytocentric overview of their ecological rolesJournal of Chemical Ecology, 1994
- Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristineZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Chemical substitution for 1,1,1-trichloroethane and methanol in an industrial cleaning operationJournal of Hazardous Materials, 1992